Essay for the CIHR/CMAJ award: Impact of the perioperative ischemic evaluation (POISE) trial

CMAJ. Canadian Medical Association Journal

Volumn 183, Issue 6, 2011, Pages

  Devereaux, Philip J ^a   Guyatt, Gordon ^a   Yang, Homer ^b   Yusuf, Salim ^a  

^a MCMASTER UNIVERSITY   (Canada)

^b UNIVERSITY OF OTTAWA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CLONIDINE; METOPROLOL; METOPROLOL SUCCINATE; PLACEBO;

ARTICLE; BRADYCARDIA; FOLLOW UP; HEART ARREST; HEART DEATH; HEART INFARCTION; HUMAN; HYPOTENSION; LOW DRUG DOSE; MAJOR SURGERY; NONCARDIAC SURGERY; PERIOPERATIVE PERIOD; RANDOMIZED CONTROLLED TRIAL (TOPIC); RISK REDUCTION; STROKE;

EID: 79953812781     PISSN: 08203946     EISSN: 14882329     Source Type: Journal    
DOI: 10.1503/cmaj.110292     Document Type: Article

References (16)

1. Weiser TG, Regenbogen SE, Thompson KD, et al. An estimation of the global volume of surgery: a modelling strategy based on available data. Lancet 2008;372:139-44.
2. Devereaux PJ, Chan M, Eikelboom J. Major vascular complications in patients undergoing noncardiac surgery: magnitude of the problem, risk prediction, surveillance, and prevention. In: Yusuf S, Cairns JA, Camm AJ, et al., editors. Evidence based cardiology. 3rd ed. West Sussex (UK): Wiley-Blackwell; 2010. p. 47-62.
3. Centers for Disease Control and Prevention (CDC). The Global HIV/AIDS pandemic, 2006. MMWR Morb Mortal Wkly Rep 2006;55:841-4.
4. Devereaux PJ, Yang H, Yusuf S, et al. Effects of extended-release metoprolol succinate in patients undergoing non-cardiac surgery (POISE trial): a randomised controlled trial. Lancet 2008;371:1839-47.
5. Mangano DT, Layug EL, Wallace A, et al. Effect of atenolol on mortality and cardiovascular morbidity after noncardiac surgery. Multicenter Study of Perioperative Ischemia Research Group. N Engl J Med 1996;335:1713-20. (Pubitemid 26399345)
6. Poldermans D, Boersma E, Bax JJ, et al. The effect of bisoprolol on perioperative mortality and myocardial infarction in high-risk patients undergoing vascular surgery. Dutch Echocardiographic Cardiac Risk Evaluation Applying Stress Echocardiography Study Group. N Engl J Med 1999;341:1789-94.
7. Palda VA, Detsky AS. Perioperative assessment and management of risk from coronary artery disease. Ann Intern Med 1997; 127:313-28. (Pubitemid 27352055)
8. Eagle KA, Berger PB, Calkins H, et al. ACC/AHA guideline update for perioperative cardiovascular evaluation for noncardiac surgery - executive summary a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Update the 1996 Guidelines on Perioperative Cardiovascular Evaluation for Noncardiac Surgery). Circulation 2002;105:1257-67.
9. Yang H, Raymer K, Butler R, et al. The effects of perioperative beta-blockade: results of the Metoprolol after Vascular Surgery (MaVS) study, a randomized controlled trial. Am Heart J 2006;152:983-90. (Pubitemid 44632958)
10. Juul AB, Wetterslev J, Gluud C, et al. Effect of perioperative beta blockade in patients with diabetes undergoing major noncardiac surgery: randomised placebo controlled, blinded multi-centre trial. BMJ 2006;332:1482.
11. Fleisher LA, Beckman JA, Brown KA, et al. ACC/AHA 2007 Guidelines on perioperative cardiovascular evaluation and care for noncardiac surgery: Executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 2002 Guidelines on Perioperative Cardiovascular Evaluation for Non-cardiac Surgery) developed in collaboration with the American Society of Echocardiography, American Society of Nuclear Cardiology, Heart Rhythm Society, Society of Cardiovascular Anesthesiologists, Society for Cardiovascular Angiography and Interventions, Society for Vascular Medicine and Biology, and Society for Vascular Surgery. [published erratum in J Am Coll Cardiol 2008; 52:794-7.]. J Am Coll Cardiol 2007;50:1707-32.
12. Devereaux PJ, Yang H, Guyatt GH, et al. Rationale, design, and organization of the perioperative ischemic evaluation (POISE) trial: a randomized controlled trial of metoprolol versus placebo in patients undergoing noncardiac surgery. Am Heart J 2006;152:223-30.
13. London MJ. Quo vadis, perioperative beta blockade? Are you "POISE'd" on the brink? Anesth Analg 2008;106:1025-30.
14. Wallace AW, Galindez D, Salahieh A, et al. Effect of clonidine on cardiovascular morbidity and mortality after noncardiac surgery. Anesthesiology 2004;101:284-93. (Pubitemid 38988482)
15. Ellis JE, Drijvers G, Pedlow S, et al. Premedication with oral and transdermal clonidine provides safe and efficacious post-operative sympatholysis. Anesth Analg 1994;79:1133-40. (Pubitemid 24363619)
16. Devereaux PJ, Beattie WS, Choi PT, et al. How strong is the evidence for the use of perioperative beta blockers in noncardiac surgery? Systematic review and meta-analysis of randomised controlled trials. BMJ 2005;331:313-21.